S

Scandion Oncology

13 employees

Scandion Oncology develops drugs that specifically target chemotherapy resistance mechanisms.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Pharmaceutical

Date founded

2017

Funding rounds raised

Total raised

$723K

from 2 investors over 2 rounds

S

Scandion Oncology raised $723K on February 19, 2020

Investors: Innovation Fund Denmark

S

Scandion Oncology raised $82K on January 1, 2019

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ